IM CANNABIS CORP (IMCC) Stock Price, Forecast & Analysis
USA - NASDAQ:IMCC - CA44969Q4060 - Common Stock
IMCC Key Statistics, Chart & Performance
The current stock price of IMCC is 1.29 USD. In the past month the price decreased by -33.16%. In the past year, price decreased by -39.15%.
IMCC Latest News, Press Relases and Analysis
IMCC Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 42.04 | 874.88B | ||
| JNJ | JOHNSON & JOHNSON | 17.97 | 449.32B | ||
| MRK | MERCK & CO. INC. | 9.79 | 215.51B | ||
| PFE | PFIZER INC | 7.63 | 138.90B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.12 | 95.03B | ||
| ZTS | ZOETIS INC | 18.97 | 53.29B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.38 | 22.49B | ||
| VTRS | VIATRIS INC | 4.34 | 11.80B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.39 | 10.68B | ||
| CORT | CORCEPT THERAPEUTICS INC | 83.77 | 7.77B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.89B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 3.77B |
Related stock screener links
About IMCC
Company Profile
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
Company Info
IM CANNABIS CORP
Kibbutz Glil Yam
TORONTO ONTARIO IL
CEO: Oren Shuster
Employees: 55
Phone: 14162564202
IM CANNABIS CORP / IMCC FAQ
What does IMCC do?
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company employs 55 full-time employees The company went IPO on 2019-11-05. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.
What is the current price of IMCC stock?
The current stock price of IMCC is 1.29 USD. The price decreased by -2.27% in the last trading session.
What is the dividend status of IM CANNABIS CORP?
IMCC does not pay a dividend.
What is the ChartMill rating of IM CANNABIS CORP stock?
IMCC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Which stock exchange lists IMCC stock?
IMCC stock is listed on the Nasdaq exchange.
How is the valuation of IM CANNABIS CORP (IMCC) based on its PE ratio?
IM CANNABIS CORP (IMCC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.4).
Can you provide the market cap for IM CANNABIS CORP?
IM CANNABIS CORP (IMCC) has a market capitalization of 6.77M USD. This makes IMCC a Nano Cap stock.
IMCC Technical Analysis
IMCC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IMCC. IMCC may be in some trouble as it scores bad on both profitability and health.
IMCC Financial Highlights
Over the last trailing twelve months IMCC reported a non-GAAP Earnings per Share(EPS) of -2.4. The EPS decreased by -78.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -10.43% | ||
| ROE | -88.04% | ||
| Debt/Equity | 2.52 |
IMCC Forecast & Estimates
For the next year, analysts expect an EPS growth of 86.24% and a revenue growth 41.23% for IMCC